S. Ley (Munich, Germany), J. Coolen (Leuven, Belgium)
Functional lung MRI in COPD: Comparative assessment of T1 mapping, oxygen-enhanced T1 mapping and perfusion MRI at 1.5 Tesla
B. Jobst, S. Triphan, O. Sedlaczek, A. Anjorin, H. U. Kauczor, J. Biederer, J. Ley-Zaporozhan, S. Ley, M. Wielpütz (Heidelberg, Munich, Würzburg, Germany)
|  |
Evaluation of whole lung 3D dynamic oxygen-enhanced MRI
J. Ulloa, A. Morgan, G. Parker (Manchester, United Kingdom)
|   |
Evaluation of T1-mapping magnetic resonance imaging for the detection of chronic lung allograft dysfunction
J. Renne, P. Lauermann, J. Hinrichs, C. Schönfeld, S. Sorrentino, M. Gutberlet, P. Jakob, A. Haverich, G. Warnecke, T. Welte, F. Wacker, J. Gottlieb, J. Vogel-Claussen (Hannover, Würzburg, Germany)
| |
Quantitative dynamic contrast-enhanced MRI of the lung in asthma
W. J. Zhang, R. Niven, S. Young, Y. Z. Liu, G. Parker, J. Naish (Manchester, Alderley Park, United Kingdom)
| |
Quantitative lung T1 mapping and oxygen enhanced MRI in IPF
K. Hart, H. Marshall, N. Stewart, M. Whyte, J. Wild (Sheffield, United Kingdom)
| |
The utility of cardiac magnetic resonance imaging in the diagnosis of cardiac sarcoidosis
K. Stanton, M. Ganigara, T. Corte, P. Torzillo, D. Celermajer, P. Corte, R. Puranik (Sydney, Australia)
| |
Feasibility of high quality lung MRI with naturally-abundant hyperpolarised 129Xe
N. J. Stewart, G. Norquay, H. Marshall, J. M. Wild (Sheffield, United Kingdom)
| |